Listed

DNA X, Inc.

SONMNasdaqCIK 1178697TechnologyFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$16.2m, Q3 FY2025
Operating income−$1.3m, Q2 FY2026
Net income−$1.2m, Q2 FY2026
DNA X, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m27.6Revenue, Q3 FY2023, three months to 2023-09-30$27.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure13.4Revenue, Q4 FY2023, three months to 2023-12-31$13.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure9.1Revenue, Q1 FY2024, three months to 2024-03-31$9.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure11.5Revenue, Q2 FY2024, three months to 2024-06-30$11.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure15.0Revenue, Q3 FY2024, three months to 2024-09-30$15.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure15.3Revenue, Q4 FY2024, three months to 2024-12-31$15.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure16.7Revenue, Q1 FY2025, three months to 2025-03-31$16.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure11.2Revenue, Q2 FY2025, three months to 2025-06-30$11.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure16.2Revenue, Q3 FY2025, three months to 2025-09-30$16.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figurenot reportednot reportednot reported
Cost of revenue$m22.0Cost of revenue, Q3 FY2023, three months to 2023-09-30$22.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure8.3Cost of revenue, Q4 FY2023, three months to 2023-12-31$8.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure13.9Cost of revenue, Q1 FY2024, three months to 2024-03-31$13.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure8.5Cost of revenue, Q2 FY2024, three months to 2024-06-30$8.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure10.8Cost of revenue, Q3 FY2024, three months to 2024-09-30$10.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure15.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$15.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure8.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$8.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure10.3Cost of revenue, Q2 FY2025, three months to 2025-06-30$10.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure14.4Cost of revenue, Q3 FY2025, three months to 2025-09-30$14.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figurenot reportednot reportednot reported
Gross profit$m5.6Gross profit, Q3 FY2023, three months to 2023-09-30$5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure5.1Gross profit, Q4 FY2023, three months to 2023-12-31$5.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure2.9Gross profit, Q1 FY2024, three months to 2024-03-31$2.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure3.0Gross profit, Q2 FY2024, three months to 2024-06-30$3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure4.2Gross profit, Q3 FY2024, three months to 2024-09-30$4.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure(0.2)Gross profit, Q4 FY2024, three months to 2024-12-31−$183.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure8.4Gross profit, Q1 FY2025, three months to 2025-03-31$8.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure0.8Gross profit, Q2 FY2025, three months to 2025-06-30$845.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure1.8Gross profit, Q3 FY2025, three months to 2025-09-30$1.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figurenot reportednot reportednot reported
Research and development$m0.7Research and development, Q3 FY2023, three months to 2023-09-30$741.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure0.9Research and development, Q4 FY2023, three months to 2023-12-31$926.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure0.5Research and development, Q1 FY2024, three months to 2024-03-31$456.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure0.6Research and development, Q2 FY2024, three months to 2024-06-30$557.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure0.7Research and development, Q3 FY2024, three months to 2024-09-30$715.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure12.5Research and development, Q4 FY2024, three months to 2024-12-31$12.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure1.6Research and development, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure0.9Research and development, Q2 FY2025, three months to 2025-06-30$909.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure0.2Research and development, Q3 FY2025, three months to 2025-09-30$181.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figurenot reportednot reportednot reported
Operating income$m0.7Operating income, Q3 FY2023, three months to 2023-09-30$688.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure(1.3)Operating income, Q4 FY2023, three months to 2023-12-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure(2.7)Operating income, Q1 FY2024, three months to 2024-03-31−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure(6.5)Operating income, Q2 FY2024, three months to 2024-06-30−$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure(2.4)Operating income, Q3 FY2024, three months to 2024-09-30−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure8.4Operating income, Q4 FY2024, three months to 2024-12-31$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figure(0.9)Operating income, Q1 FY2025, three months to 2025-03-31−$870.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(1.5)Operating income, Q2 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure(4.0)Operating income, Q3 FY2025, three months to 2025-09-30−$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure4.7Operating income, Q4 FY2025, three months to 2025-12-31$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figure(3.6)Operating income, Q1 FY2026, three months to 2026-03-31−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(1.3)Operating income, Q2 FY2026, three months to 2026-06-30−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001493152-23-041079. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reportednot reportednot reported0.1Interest expense, Q1 FY2025, three months to 2025-03-31$71.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure0.2Interest expense, Q2 FY2025, three months to 2025-06-30$161.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure0.3Interest expense, Q3 FY2025, three months to 2025-09-30$339.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure0.4Interest expense, Q4 FY2025, three months to 2025-12-31$374.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2026, three months to 2026-03-31$131.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figurenot reported
Income tax$m0.1Income tax, Q3 FY2023, three months to 2023-09-30$96.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-31$93.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2024, three months to 2024-03-31$125.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$37.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure0.1Income tax, Q3 FY2024, three months to 2024-09-30$117.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure(0.1)Income tax, Q4 FY2024, three months to 2024-12-31−$53.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2025-03-31$132.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure0.1Income tax, Q2 FY2025, three months to 2025-06-30$138.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure0.1Income tax, Q3 FY2025, three months to 2025-09-30$90.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure(1.5)Income tax, Q4 FY2025, three months to 2025-12-31−$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figure2.5Income tax, Q1 FY2026, three months to 2026-03-31$2.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(0.2)Income tax, Q2 FY2026, three months to 2026-06-30−$243.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure
Net income$m0.5Net income, Q3 FY2023, three months to 2023-09-30$527.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure(1.4)Net income, Q4 FY2023, three months to 2023-12-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure(2.9)Net income, Q1 FY2024, three months to 2024-03-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure(6.6)Net income, Q2 FY2024, three months to 2024-06-30−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure(2.5)Net income, Q3 FY2024, three months to 2024-09-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure(21.6)Net income, Q4 FY2024, three months to 2024-12-31−$21.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figure0.5Net income, Q1 FY2025, three months to 2025-03-31$458.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(7.5)Net income, Q2 FY2025, three months to 2025-06-30−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure(4.8)Net income, Q3 FY2025, three months to 2025-09-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure(8.9)Net income, Q4 FY2025, three months to 2025-12-31−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figure6.3Net income, Q1 FY2026, three months to 2026-03-31$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(1.2)Net income, Q2 FY2026, three months to 2026-06-30−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure
Diluted EPS$ per share0.12Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figurenot reported(0.65)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure(1.41)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure(9.32)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$9.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figurenot reported1.41Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(14.15)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$14.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure(4.83)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$4.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figurenot reported5.01Diluted EPS, Q1 FY2026, three months to 2026-03-31$5.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(0.92)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure
Basic EPS$ per share0.12Basic EPS, Q3 FY2023, three months to 2023-09-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figurenot reported(0.65)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure(1.41)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure(9.32)Basic EPS, Q3 FY2024, three months to 2024-09-30−$9.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figurenot reported1.41Basic EPS, Q1 FY2025, three months to 2025-03-31$1.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(14.15)Basic EPS, Q2 FY2025, three months to 2025-06-30−$14.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure(4.83)Basic EPS, Q3 FY2025, three months to 2025-09-30−$4.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figurenot reported5.01Basic EPS, Q1 FY2026, three months to 2026-03-31$5.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(0.92)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure

Balance sheet

Cash and equivalents$900.0k, Q2 FY2026
Long-term debt$1.1m, Q1 FY2026
Shareholders' equity−$1.2m, Q2 FY2026
DNA X, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m9.8Cash and equivalents, Q3 FY2023, at 2023-09-30$9.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001493152-23-041079.Report this figure9.4Cash and equivalents, FY2023, at 2023-12-31$9.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001641172-25-001720.Report this figure9.3Cash and equivalents, Q1 FY2024, at 2024-03-31$9.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001493152-24-019245.Report this figure9.6Cash and equivalents, Q2 FY2024, at 2024-06-30$9.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0001493152-24-030969.Report this figure9.1Cash and equivalents, Q3 FY2024, at 2024-09-30$9.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure5.3Cash and equivalents, FY2024, at 2024-12-31$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-04-15, accession 0001493152-26-016659.Report this figure2.1Cash and equivalents, Q1 FY2025, at 2025-03-31$2.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure2.0Cash and equivalents, Q2 FY2025, at 2025-06-30$2.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure2.1Cash and equivalents, Q3 FY2025, at 2025-09-30$2.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure1.3Cash and equivalents, FY2025, at 2025-12-31$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure1.2Cash and equivalents, Q1 FY2026, at 2026-03-31$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure0.9Cash and equivalents, Q2 FY2026, at 2026-06-30$900.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure
Current assets$m47.5Current assets, Q3 FY2023, at 2023-09-30$47.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041079.Report this figure43.8Current assets, FY2023, at 2023-12-31$43.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001720.Report this figure29.5Current assets, Q1 FY2024, at 2024-03-31$29.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001493152-24-019245.Report this figure32.6Current assets, Q2 FY2024, at 2024-06-30$32.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001493152-24-030969.Report this figure33.9Current assets, Q3 FY2024, at 2024-09-30$33.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure32.2Current assets, FY2024, at 2024-12-31$32.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-04-15, accession 0001493152-26-016659.Report this figure26.9Current assets, Q1 FY2025, at 2025-03-31$26.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure27.1Current assets, Q2 FY2025, at 2025-06-30$27.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure30.3Current assets, Q3 FY2025, at 2025-09-30$30.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure28.9Current assets, FY2025, at 2025-12-31$28.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure3.3Current assets, Q1 FY2026, at 2026-03-31$3.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure2.9Current assets, Q2 FY2026, at 2026-06-30$2.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure
Total assets$m58.6Total assets, Q3 FY2023, at 2023-09-30$58.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001493152-23-041079.Report this figure56.0Total assets, FY2023, at 2023-12-31$56.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001641172-25-001720.Report this figure42.4Total assets, Q1 FY2024, at 2024-03-31$42.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001493152-24-019245.Report this figure45.9Total assets, Q2 FY2024, at 2024-06-30$45.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001493152-24-030969.Report this figure49.1Total assets, Q3 FY2024, at 2024-09-30$49.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure39.7Total assets, FY2024, at 2024-12-31$39.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-04-15, accession 0001493152-26-016659.Report this figure36.0Total assets, Q1 FY2025, at 2025-03-31$36.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure36.1Total assets, Q2 FY2025, at 2025-06-30$36.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure40.2Total assets, Q3 FY2025, at 2025-09-30$40.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure43.9Total assets, FY2025, at 2025-12-31$43.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure4.8Total assets, Q1 FY2026, at 2026-03-31$4.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure4.5Total assets, Q2 FY2026, at 2026-06-30$4.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure
Current liabilities$m34.0Current liabilities, Q3 FY2023, at 2023-09-30$34.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041079.Report this figure32.1Current liabilities, FY2023, at 2023-12-31$32.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001720.Report this figure21.0Current liabilities, Q1 FY2024, at 2024-03-31$21.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001493152-24-019245.Report this figure26.9Current liabilities, Q2 FY2024, at 2024-06-30$26.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0001493152-24-030969.Report this figure32.2Current liabilities, Q3 FY2024, at 2024-09-30$32.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure43.7Current liabilities, FY2024, at 2024-12-31$43.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-04-15, accession 0001493152-26-016659.Report this figure34.7Current liabilities, Q1 FY2025, at 2025-03-31$34.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure35.7Current liabilities, Q2 FY2025, at 2025-06-30$35.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure38.9Current liabilities, Q3 FY2025, at 2025-09-30$38.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure50.6Current liabilities, FY2025, at 2025-12-31$50.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure4.3Current liabilities, Q1 FY2026, at 2026-03-31$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure5.1Current liabilities, Q2 FY2026, at 2026-06-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure
Total liabilities$m35.5Total liabilities, Q3 FY2023, at 2023-09-30$35.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001493152-23-041079.Report this figure33.7Total liabilities, FY2023, at 2023-12-31$33.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001641172-25-001720.Report this figure22.5Total liabilities, Q1 FY2024, at 2024-03-31$22.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001493152-24-019245.Report this figure28.4Total liabilities, Q2 FY2024, at 2024-06-30$28.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001493152-24-030969.Report this figure33.8Total liabilities, Q3 FY2024, at 2024-09-30$33.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure45.4Total liabilities, FY2024, at 2024-12-31$45.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-04-15, accession 0001493152-26-016659.Report this figure37.0Total liabilities, Q1 FY2025, at 2025-03-31$37.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure37.4Total liabilities, Q2 FY2025, at 2025-06-30$37.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure40.9Total liabilities, Q3 FY2025, at 2025-09-30$40.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure50.6Total liabilities, FY2025, at 2025-12-31$50.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure4.9Total liabilities, Q1 FY2026, at 2026-03-31$4.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure5.7Total liabilities, Q2 FY2026, at 2026-06-30$5.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reported0.6Long-term debt, Q1 FY2025, at 2025-03-31$566.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure2.9Long-term debt, Q2 FY2025, at 2025-06-30$2.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure0.3Long-term debt, Q3 FY2025, at 2025-09-30$250.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure5.1Long-term debt, FY2025, at 2025-12-31$5.1m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-04-15, accession 0001493152-26-016659.Report this figure1.1Long-term debt, Q1 FY2026, at 2026-03-31$1.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figurenot reported
Current portion of debt$m0.0Current portion of debt, Q3 FY2023, at 2023-09-30$37.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041079.Report this figurenot reportednot reportednot reportednot reportednot reported2.3Current portion of debt, Q1 FY2025, at 2025-03-31$2.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure2.9Current portion of debt, Q2 FY2025, at 2025-06-30$2.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure4.8Current portion of debt, Q3 FY2025, at 2025-09-30$4.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure5.1Current portion of debt, FY2025, at 2025-12-31$5.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-04-15, accession 0001493152-26-016659.Report this figure1.1Current portion of debt, Q1 FY2026, at 2026-03-31$1.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figurenot reported
Shareholders' equity$m23.1Shareholders' equity, Q3 FY2023, at 2023-09-30$23.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure22.4Shareholders' equity, FY2023, at 2023-12-31$22.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-04-15, accession 0001493152-26-016659.Report this figure19.8Shareholders' equity, Q1 FY2024, at 2024-03-31$19.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure17.5Shareholders' equity, Q2 FY2024, at 2024-06-30$17.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure15.3Shareholders' equity, Q3 FY2024, at 2024-09-30$15.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure(5.7)Shareholders' equity, FY2024, at 2024-12-31−$5.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure(1.1)Shareholders' equity, Q1 FY2025, at 2025-03-31−$1.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure(1.3)Shareholders' equity, Q2 FY2025, at 2025-06-30−$1.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure(0.7)Shareholders' equity, Q3 FY2025, at 2025-09-30−$701.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure(8.0)Shareholders' equity, FY2025, at 2025-12-31−$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure(1.0)Shareholders' equity, Q1 FY2026, at 2026-03-31−$983.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure(1.2)Shareholders' equity, Q2 FY2026, at 2026-06-30−$1.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure

Cash flow

Operating cash flow−$2.0m, Q2 FY2026
Capital expenditure$8.0k, Q4 FY2024
DNA X, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(304)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$304.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001493152-24-045139. Derived: 9-month figure less the 6-month figure.Report this figure(351)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$351.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure(168)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$168.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure(3,392)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001641172-25-022821. Derived: 6-month figure less the 3-month figure.Report this figure(417)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$417.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0001493152-25-020310. Derived: 9-month figure less the 6-month figure.Report this figure(4,509)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figure(9,606)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(4,882)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-19, accession 0001493152-26-039226. Derived: 6-month figure less the 3-month figure.Report this figure(7,034)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-31, accession 0001493152-25-020310. Derived: 9-month figure less the 6-month figure.Report this figure(2,004)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figure(3,466)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure(2,001)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-19, accession 0001493152-26-039226. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k1.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001493152-24-045139. Derived: 9-month figure less the 6-month figure.Report this figure12.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001641172-25-001720. Derived: 12-month figure less the 9-month figure.Report this figure30.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$30.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure39.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$39.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-08, accession 0001641172-25-022821. Derived: 6-month figure less the 3-month figure.Report this figure137Capital expenditure, Q3 FY2024, three months to 2024-09-30$137.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-31, accession 0001493152-25-020310. Derived: 9-month figure less the 6-month figure.Report this figure8.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-04-15, accession 0001493152-26-016659. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)1.35m, Q2 FY2026
DNA X, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares36.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3036,085,226 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001493152-23-041079.Report this figure41.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3141,095,901 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001493152-24-019245.Report this figure4.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-304,458,577 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0001493152-24-030969.Report this figure4.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-304,418,026 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001493152-24-045139.Report this figure4.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-314,438,131 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001641172-25-009749.Report this figure4.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-304,685,352 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001641172-25-022821.Report this figure0.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30269,388 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure0.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31324,431 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure0.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30528,367 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure1.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30984,927 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-31, accession 0001493152-25-020310.Report this figure1.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,265,067 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-20, accession 0001493152-26-024644.Report this figure1.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-301,350,914 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure

Shares outstanding: 1.49mShares outstanding, period not labelled, at 2026-08-181,488,268 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-19, accession 0001493152-26-039226.Report this figure at Aug 18, 2026, from the cover of the 10-Q filed Aug 19, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.